|
|
Nanotechnology, Biology, and Medicine in SEBM’s Second
Century
Sponsored by
Society for Experimental
Biology and Medicine
Sunday, April 29 — 3:15-5:15 PM
Washington, DC Convention Center — Room 147B
|
| Chaired: |
Burton E. Sobel, Univ. of Vermont
Charles A. Blake, Univ. of South Carolina |
This symposium will address the promise of
nanotechnology in biology and medicine with respect to three general areas
including: 1) the promise of nanotechnology in prevention of disease; 2)
the promise of nanotechnology in improved diagnosis; and 3) the promise of
nanotechnology in enhanced therapy. Speakers will focus on specific
approaches taken and illustrate them with descriptions of specific
applications of nanotechnology. Examples include: 1) elucidation of
biological structures in the 5-500 nm size range and their role in
determining function particularly with respect to electron transport and
biological oxidations (Dr. S. Sliger); 2) engineered viruses for biomedical
science with consideration of their potential role in drug delivery (Dr. M.G.
Finn); and 3) applications of nanotechnology in cardiovascular surgery with
emphasis on modulation of the systemic inflammatory response syndrome (Dr.
T. Gourlay). Dr. Steven Goodman, editor of Experimental Biology and
Medicine, will present some thoughts regarding the journal’s emphasis on the
nanotechnology, informatics, integrated and multidisciplinary research in
the Society for Experimental Biology and Medicine’s second century.
|
3:15 PM |
Engineered viruses for biomedical science.
M.G. Finn, The Scripps Res. Inst.
|
|
3:45 PM |
Nanotechnology and cardiovascular surgery – an
emerging therapeutic approach.
Terence Gourlay, Imperial Col. London
|
|
4:15 PM |
Nanoscale self-assembled lipid bilayers for
elucidating the structure and function of integral membrane
proteins.
Stephen G. Sligar, Univ. of Illinois
|
|
4:45 PM |
“Experimental biology and medicine” in SEBM’s
second century.
Steven R. Goodman, Univ. of Texas at Dallas
|
|
|